MARK CHIU, M.D.
Ophthalmology Physician · ALBUQUERQUE, NM
Individual Active NPI 1821083932
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 842 | 48,522 | $6,527,854 | $3,858,784 | $3,026,076 |
| 2023 | 938 | 55,941 | $7,894,227 | $4,899,613 | $3,867,179 |
| 2022 | 926 | 20,954 | $8,051,717 | $5,043,691 | $3,969,951 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 39,912 | $35 | $28 |
| 67028 | Injection of drug into eye | 1,800 | $118 | $86 |
| J0178 | Injection, aflibercept, 1 mg | 1,730 | $827 | $656 |
| 92134 | Imaging of retina | 1,262 | $37 | $26 |
| J2778 | Injection, ranibizumab, 0.1 mg | 639 | $161 | $128 |
| J0177 | Injection, aflibercept hd, 1 mg | 606 | $333 | $265 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 460 | $121 | $61 |
| J7999 | Compounded drug, not otherwise classified | 308 | $84 | $64 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 301 | $202 | $161 |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 264 | $323 | $257 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 161 | $86 | $61 |
| 92014 | Established patient complete exam of visual system | 155 | $116 | $89 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 88-17 | NM |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in New Mexico
- NPI 1295717833
- NPI 1548226277
- NPI 1629269352
- NPI 1043370554
- NPI 1417165721
- NPI 1962417410
- NPI 1700871894
- NPI 1316937295
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.